CL Educate Intrinsic Value
CLEDUCATE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹46.56 | ₹37.25 - ₹55.87 | +22.3% | EPS: ₹3.88, Sector P/E: 12x |
| Book Value Method | asset | ₹95.15 | ₹85.64 - ₹104.67 | +150.0% | Book Value/Share: ₹99.63, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹76.12 | ₹68.51 - ₹83.73 | +100.0% | Revenue/Share: ₹250.37, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹76.12 | ₹68.51 - ₹83.73 | +100.0% | EBITDA: ₹108.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹55.02 | ₹44.02 - ₹66.02 | +44.6% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹24.83 | ₹22.35 - ₹27.31 | -34.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹31.97 | ₹28.77 - ₹35.17 | -16.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹74.07 | ₹66.66 - ₹81.48 | +94.6% | ROE: 7.4%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹93.26 | ₹83.93 - ₹102.59 | +145.0% | EPS: ₹3.88, BVPS: ₹99.63 |
Want to compare with current market value? Check CLEDUCATE share price latest .
Valuation Comparison Chart
CLEDUCATE Intrinsic Value Analysis
What is the intrinsic value of CLEDUCATE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of CL Educate (CLEDUCATE) is ₹74.07 (median value). With the current market price of ₹38.06, this represents a +94.6% variance from our estimated fair value.
The valuation range spans from ₹24.83 to ₹95.15, indicating ₹24.83 - ₹95.15.
Is CLEDUCATE undervalued or overvalued?
Based on our multi-method analysis, CL Educate (CLEDUCATE) appears to be trading below calculated value by approximately 94.6%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.16 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 7.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.75x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for CL Educate
Additional stock information and data for CLEDUCATE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹16 Cr | ₹-105 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹26 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹23 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹33 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹26 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |